asthma management in children Flashcards

1
Q

is there a cure for asthma

A

no, only palliation/spontaneous resolution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

goals of treatment

A
minimal symptoms during day/night 
minimal need for reliever medication
no attacks
no limitation of physical activity
normal lung function (FEV1 and/or PEF >80% predicted/best)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

measuring control of asthma (SANE)

A

Short acting beta agonist /wk: if used >3 days, poorly controlled, = 2 days is well controlled
Absence from school/nursery
Nocturnal symptoms/wk: waking 1 night/wk = poor control
Exertional symptoms/wk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

treatment decisions (possible change)

A

are symptoms being controlled
is treatment being taken
will changing the treatment help

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what to do if asthma is well controlled

A

no change or reduce treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what to do if asthma isn’t well controlled

A

not taking treatment
not taking treatment correctly
(if either of the above 2, dont change treatment)

not asthma - stop asthma treatment
none of the above - increase asthma treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

step up step down approach

A

started on low dose ICS - severe may respond to minimal treatment
review after 2mths - no routine test to monitor progress
no change is easier than step down if symptoms have responded
need an inhaler holiday (easter) - given inhaler, take a break when not at school/nursery to see if symptoms resolve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

use of steroids in childhood asthma

A

child hood asthma is very steroid sensitive
chronic/maintenance: ICS
acute treatment: oral steroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

classes of medication

A

SABAs
ICS
oral steroids

add ons:
long acting beta2 agonists (LABA)
leukotriene receptor agonists
theophyllines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

inhaled corticosteroids

A

very useful for diagnosis
very effective and safe
not much +ve effect when going from middle - high dose but many more adverse effects (heigh suppression, oral thrush, adrenocortical suppression - esp w/ fluticasone, hypertension, cataracts)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

2016 BTS/SIGN guidelines

A

one figure for all children
ICS doses overlap w/ adults
acknowledges areas of uncertainty when ICS aren’t sufficient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

contrast w/ adult treatment

A

max dose ICS 800 microg (<12y/o), 2000 in adults
no oral beta2 tablet in children
LTRA 1st line preventer in <5s (not used in adults)
no LAMAs (long acting muscarinic antagonists, only used for adults currently)
only 2 biologicals in children, many more options in adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

step 2 - regular preventer

A

diagnostic test
beta 2 agonist: >2days/wk, symptomatic (>/= 3 days/wk or waking 1 night/wk)
exacerbations of asthma in the last 2 yrs
start w/ v low dose of ICS (or LTRA in <5s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

add on preventer - LABA

A

useful for patients w/ lots of exertional symptoms
DO NOT USE W/O ICS
use as fixed dose inhaler (one inhaler w/ both medications)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

add on preventer - LTRA

A

montelukast only
1/3 respond well, 1/3 respond slightly, 1/3 dont respond at al
better adherence than inhalers
granules for reluctant toddlers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

step 3 - inital add on preventer

A

add on LABA/LTRA (BTS/SIGN)
add on LTRA (NICE)
increase ICS dose (GINA)

ADD ON LABA WHEN PATIENT ISNT RESPONDING TO ICS

17
Q

severe asthma management

A

refer to specialist

generally due to lack of compliance w/ inhalers or not taking them properly

18
Q

delivery systems

A

MDI/spacer
DPIs
nebulisers

19
Q

MDI/spacer

A

<5% lung deposition w/o spacer
= 20% lung deposition w/ spacer
shake inhaler between puffs and wash spacer monthly to reduce static

20
Q

what do spacers do

A

hold the dose and allows the patient to breathe it in at their own pace
easier for children to use than co-ordinating breathing w/ pressing inhaler

21
Q

DPIs

A

licensed in over 5s
under 8s can’t use them
20% lung deposition

22
Q

nebulisers

A

not indicated for day-to-day use
MDI spacer vs nebuliser:
quieter, quicker, valve mechanism, don’t break down, portable, cheaper

23
Q

deposition w/ infants

A

loosely fitting face mask - 0.1%
crying during inhalation - 1%, lots ends up in stomach
quietly inhaling - 8%

24
Q

non-medicinal intervention

A

stop tobacco smoke exposure
remove environmental triggers
diet (evidence -ve)
alter humidity (no evidence, air ionisers increase cough)
weight reduction (no evidence that it reduces asthma in children)

25
Q

mild acute asthma treatment

A

SABA via spacer

SABA via spacer + prednisolone

26
Q

moderate acute asthma treatment

A

marked increased RR and increased work of breathing
SABA via neb + prednisolone
SABA and ipratropium via neb and prednisolone

27
Q

advantage of nebuliser over spacer

A

neb is superior for moderate asthma treatment

delivers large amounts of salbutamol to buccal mucosa where it can be absorbed

28
Q

severe acute asthma treatment

A
IV salbutamol
IV aminophylline
IV magnesium (neb) - same effects as hydrocortisone 
IV hydrocortisone 
intubate and ventilate
29
Q

when are IV steroids given

A

when child is vomiting, hypoxic or in a coma

30
Q

things to look for in acute asthma

A
HR and RR
work of breathing 
O2 sats
ability to complete sentences
confusion 
air entry